| Pyrrolizidine alkaloids—genotoxicity, metabolism enzymes, metabolic activation, and mechanisms PP Fu, Q Xia, G Lin, MW Chou Drug metabolism reviews 36 (1), 1-55, 2004 | 634 | 2004 |
| Unambiguous observation of shape effects on cellular fate of nanoparticles Z Chu, S Zhang, B Zhang, C Zhang, CY Fang, I Rehor, P Cigler, ... Scientific reports 4 (1), 4495, 2014 | 303 | 2014 |
| Hepatic sinusoidal obstruction syndrome associated with consumption of Gynura segetum G Lin, JY Wang, N Li, M Li, H Gao, Y Ji, F Zhang, H Wang, Y Zhou, Y Ye, ... Journal of Hepatology 54 (4), 666-673, 2011 | 280 | 2011 |
| Pharmacological effects and pharmacokinetics properties of Radix Scutellariae and its bioactive flavones C Li, G Lin, Z Zuo Biopharmaceutics & drug disposition 32 (8), 427-445, 2011 | 273 | 2011 |
| Controllable Drug Release and Simultaneously Carrier Decomposition of SiO2-Drug Composite Nanoparticles S Zhang, Z Chu, C Yin, C Zhang, G Lin, Q Li Journal of the American Chemical Society 135 (15), 5709-5716, 2013 | 242 | 2013 |
| Pyrrolizidine alkaloids-tumorigenic components in Chinese herbal medicines and dietary supplements PP Fu, YC Yang, Q Xia, MW Chou, YY Cui, G Lin Journal of Food and Drug Analysis 10 (4), 198-211, 2002 | 209 | 2002 |
| Intestinal and hepatic glucuronidation of flavonoids L Zhang, Z Zuo, G Lin Molecular pharmaceutics 4 (6), 833-845, 2007 | 208 | 2007 |
| Antitussive activity of Stemona alkaloids from Stemona tuberosa HS Chung, PM Hon, G Lin, PPH But, H Dong Planta medica 69 (10), 914-920, 2003 | 187 | 2003 |
| Simultaneous quantification of five major biologically active ingredients of saffron by high-performance liquid chromatography N Li, G Lin, YW Kwan, ZD Min Journal of Chromatography A 849 (2), 349-355, 1999 | 185 | 1999 |
| Chemistry and biological activities of naturally occurring phthalides G Lin, SSK Chan, HS Chung, SL Li Studies in natural products chemistry 32, 611-669, 2005 | 180 | 2005 |
| Metabolic activation of pyrrolizidine alkaloids: insights into the structural and enzymatic basis J Ruan, M Yang, P Fu, Y Ye, G Lin Chemical research in toxicology 27 (6), 1030-1039, 2014 | 164 | 2014 |
| Relaxation effects of ligustilide and senkyunolide A, two main constituents of Ligusticum chuanxiong, in rat isolated aorta SSK Chan, TY Cheng, G Lin Journal of Ethnopharmacology 111 (3), 677-680, 2007 | 162 | 2007 |
| Pharmacokinetics and metabolism of ligustilide, a major bioactive component in Rhizoma Chuanxiong, in the rat R Yan, NL Ko, SL Li, YK Tam, G Lin Drug Metabolism and Disposition 36 (2), 400-408, 2008 | 158 | 2008 |
| Role of intestinal first-pass metabolism of baicalein in its absorption process L Zhang, G Lin, Q Chang, Z Zuo Pharmaceutical Research 22, 1050-1058, 2005 | 155 | 2005 |
| Definitive diagnosis of hepatic sinusoidal obstruction syndrome induced by pyrrolizidine alkaloids H Gao, N Li, JY Wang, SC Zhang, G Lin Journal of digestive diseases 13 (1), 33-39, 2012 | 152 | 2012 |
| Study of the anti-proliferative effects and synergy of phthalides from Angelica sinensis on colon cancer cells WLT Kan, CH Cho, JA Rudd, G Lin Journal of ethnopharmacology 120 (1), 36-43, 2008 | 150 | 2008 |
| Involvement of UDP-glucuronosyltransferases in the extensive liver and intestinal first-pass metabolism of flavonoid baicalein L Zhang, G Lin, Z Zuo Pharmaceutical research 24, 81-89, 2007 | 148 | 2007 |
| Chromatographic analysis of Fritillaria isosteroidal alkaloids, the active ingredients of Beimu, the antitussive traditional Chinese medicinal herb G Lin, P Li, SL Li, SW Chan Journal of chromatography A 935 (1-2), 321-338, 2001 | 146 | 2001 |
| Simultaneous analysis of seventeen chemical ingredients of Ligusticum chuanxiong by on-line high performance liquid chromatography-diode array detector-mass spectrometry SL Li, SSK Chan, G Lin, L Ling, R Yan, HS Chung, YK Tam Planta medica 69 (05), 445-451, 2003 | 138 | 2003 |
| Hepatotoxicity and tumorigenicity induced by metabolic activation of pyrrolizidine alkaloids in herbs N Li, Q Xia, J Ruan, P P Fu, G Lin Current drug metabolism 12 (9), 823-834, 2011 | 130 | 2011 |
Peter FuNCTR在 fda.hhs.gov 的电子邮件经过验证
